Evidence map›Paper›PMID 40266062›Full record

ArticleVaccines2025

Immunization Against

Amanda L Collar, Andzoa N Jamus, Julian Flanagan, Susan B Core, William M Geisler, Cosette M Wheeler, Kathryn M Frietze

Abstract read
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Frontiers in cellular and infection microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Amanda L CollarDepartment of Molecular Genetics and Microbiology, University of New Mexico Health Sciences, Albuquerque, NM 87131, USA.ORCID 0000-0003-3214-1898
Andzoa N JamusDepartment of Molecular Genetics and Microbiology, University of New Mexico Health Sciences, Albuquerque, NM 87131, USA.ORCID 0000-0001-5342-4059
Julian FlanaganDepartment of Molecular Genetics and Microbiology, University of New Mexico Health Sciences, Albuquerque, NM 87131, USA.ORCID 0009-0000-0283-6790
Susan B CoreDepartment of Molecular Genetics and Microbiology, University of New Mexico Health Sciences, Albuquerque, NM 87131, USA.ORCID 0000-0002-4933-6598
William M GeislerDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0002-0603-2404
Cosette M WheelerCenter for HPV Prevention, University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences, Albuquerque, NM 87131, USA.
Kathryn M FrietzeDepartment of Molecular Genetics and Microbiology, University of New Mexico Health Sciences, Albuquerque, NM 87131, USA.

Funding

UNM HSC Clinical and Translational Science CenterUL1TR001449 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CAMPEN, MATTHEW J, PANDHI, NANCY · 2015 to 2024
$36.9M
The EPI-STI Biostatistics and Bioinformatics Core (Cuzick/Wheeler)U19AI113187 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI WHEELER, COSETTE MARIE · 2014 to 2018
$12.6M
Biology of Infectious Diseases &InflammationT32AI007538 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Michelle A Ozbun · 1998 to 2026
$5.2M
Mechanisms and Correlates of Immune Protection against Genital Chlamydia in HumansR01AI093692 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GEISLER, WILLIAM M · 2012 to 2023
$4.5M
University of New Mexico Clinical and Translational Science CenterKL2TR001448 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CANNON, JUDY LIN · 2015 to 2024
$3.5M
Bacteriophage virus-like particle vaccines for Chlamydia trachomatis urogenital infectionR01AI166360 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Kathryn M. Frietze · 2023 to 2026
$1.5M
University of New Mexico's CURE for CancerR25CA247794 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Jennifer Gillette, Dolores Guest · 2023 to 2026
$1.4M
Defining Chlamydia trachomatis adhesion factor epitope-specific antibody responses, functionality, and roles in protection against urogenital infectionF30AI156995 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI COLLAR, AMANDA L · 2021 to 2023
$120k
Investigation of novel chlamydia vaccines in male infection models and sexual transmission challengesF31AI179064 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI JAMUS, ANDZOA · 2023 to 2024
$75k
National Institute of Allergy and Infectious Diseases F31 AI170964NCATS NIH HHS KL2 TR001448NCATS NIH HHS UL1 TR001449NCI NIH HHS R25 CA247794NIAID NIH HHS F30 AI156995NIAID NIH HHS F31 AI179064NIAID NIH HHS R01 AI093692NIAID NIH HHS R01 AI166360NIAID NIH HHS T32 AI007538NIAID NIH HHS U19 AI113187
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chlamydiapeptide vaccinepolymorphic membrane protein D (PmpD)vaccinevirus-like particle (VLP)

Identifiers

PMID40266062
PMCPMC11946637

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.